子宫内膜异位症术后患者对认知行为疗法的看法:一项定性研究
本研究通过半结构化焦点小组访谈,探讨子宫内膜异位症术后患者对认知行为疗法(CBT)的看法及偏好形式。所有参与者认为CBT应被纳入子宫内膜异位症治疗,并期望其改善术后生活质量;患者偏好面对面个体或团体治疗,强调需个体化定制方案。
要点
- 患者认为CBT应纳入子宫内膜异位症标准治疗以改善生活质量。
- 患者偏好面对面个体或团体CBT,而非网络个体形式。
- 患者强调CBT方案需个体化定制以满足不同需求。
核心结论
- 子宫内膜异位症患者认为CBT应加入标准治疗方案,以团体或个体面对面形式提供,并期望其改善术后生活质量。
主要发现
- 所有参与女性认为应向接受子宫内膜异位症手术的患者提供CBT。
- 参与者认为CBT有助于改善生活质量。
- 参与者偏好面对面个体治疗或团体治疗。
- 参与者强调提供个体化定制治疗方案的重要性,以适应不同患者的不同需求。
临床怎么用
- 临床可考虑将CBT以面对面个体或团体形式纳入子宫内膜异位症术后管理,并注重个体化定制。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RESEARCH QUESTION: Would adding cognitive behavioural therapy (CBT) to the treatment of endometriosis improve the quality of life of patients suffering from endometriosis-associated pain? The aim of this study was to identify if patients believed CBT should be added to endometriosis treatment and which form of CBT they would prefer: face-to-face individual or group, or web-based individual, sessions. DESIGN: Between November 2019 and January 2020, semi-structured focus groups were conducted using an interview guide to ensure all topics were discussed. Data collection was continued until saturation was obtained. The focus groups were transcribed word for word and openly encoded. Finally, themes were formulated. RESULTS: All participating women believed CBT should be offered to patients undergoing endometriosis surgery. They believed it could be an asset to improve quality of life. Participants preferred either in-person individual or group therapy. They stressed the importance of being offered a custom-made treatment plan, individually tailored to the different needs of different patients. CONCLUSION: This study has shown that patients with endometriosis believe that CBT should be added to the standard treatment regimen of endometriosis in either group or individual face-to-face sessions, because they expect that CBT will improve their quality of life after surgery.
引用
- Boersen Z, de Kok L, van der Zanden M, et al. Patients' perspective on cognitive behavioural therapy after surgical treatment of endometriosis: a qualitative study. Reprod Biomed Online. 2021. PMID: 33602590. doi:10.1016/j.rbmo.2021.01.010
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。